Cancer cachexia: Developing multimodal therapy for a multidimensional problem

Sarcopenia: origins and clinical relevance

Rosenberg, I. H. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.5.990s · Cited by 2,399

Prognostic effect of weight loss prior tochemotherapy in cancer patients

Dewys, W. D., Begg, C., Lavin, P. T., Band, P. R., Bennett, J. M., Bertino, J. R., Cohen, M. H., Douglass, H. O., Engstrom, P. F., Ezdinli, E. Z., et al. (1980) · The American Journal of Medicine · doi:10.1016/s0149-2918(05)80001-3 · Cited by 2,354

Double muscling in cattle due to mutations in the myostatin gene

McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039

Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle

Cuthbertson, D., Smith, K., Babraj, J., Leese, G., Waddell, T., Atherton, P., Wackerhage, H., Taylor, P. M., & Rennie, M. J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2640fje · Cited by 1,211 · cited 2×

Symptom Prevalence in Patients with Incurable Cancer: A Systematic Review

Teunissen, S. C. C. M., Wesker, W., Kruitwagen, C., de Haes, H. C. J. M., Voest, E. E., & de Graeff, A. (2007) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.10.015 · Cited by 990

Tumor Necrosis Factor, Other Cytokines and Disease

Tracey, K. J., & Cerami, A. (1993) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.09.110193.001533 · Cited by 783

Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis

Fearon, K. C., Voss, A. C., & Hustead, D. S. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1345 · Cited by 779

Muscle Protein Breakdown and the Critical Role of the Ubiquitin-Proteasome Pathway in Normal and Disease States

Lecker, S. H., Solomon, V., Mitch, W. E., & Goldberg, A. L. (1999) · The Journal of Nutrition · doi:10.1093/jn/129.1.227s · Cited by 732

Body Composition as an Independent Determinant of 5-Fluorouracil–Based Chemotherapy Toxicity

Prado, C. M. M., Baracos, V. E., McCargar, L. J., Mourtzakis, M., Mulder, K. E., Reiman, T., Butts, C. A., Scarfe, A. G., & Sawyer, M. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3067 · Cited by 619

Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial

Fearon, K. C. H. (2003) · Gut · doi:10.1136/gut.52.10.1479 · Cited by 603

Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases

Sacheck, J. M., Hyatt, J. K., Raffaello, A., Thomas Jagoe, R., Roy, R. R., Reggie Edgerton, V., Lecker, S. H., & Goldberg, A. L. (2007) · The FASEB Journal · doi:10.1096/fj.06-6604com · Cited by 585 · cited 1×

Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?

Ross, P. J., Ashley, S., Norton, A., Priest, K., Waters, J. S., Eisen, T., Smith, I. E., & O'Brien, M. E. R. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601781 · Cited by 476

Muscle Protein Synthesis Measured by Stable Isotope Techniques in Man: The Effects of Feeding and Fasting

Rennie, M. J., Edwards, R. H. T., Halliday, D., Matthews, D. E., Wolman, S. L., & Millward, D. J. (1982) · Clinical Science · doi:10.1042/cs0630519 · Cited by 455

Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids

Moses, A. W. G., Slater, C., Preston, T., Barber, M. D., & Fearon, K. C. H. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601620 · Cited by 452

Characterization of a cancer cachectic factor

Todorov, P., Cariuk, P., McDevitt, T., Coles, B., Fearon, K., & Tisdale, M. (1996) · Nature · doi:10.1038/379739a0 · Cited by 437

What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?

Jagoe, R. T., & Goldberg, A. L. (2001) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200105000-00003 · Cited by 399

Do the Differences between the Amino Acid Compositions of Acute-Phase and Muscle Proteins Have a Bearing on Nitrogen Loss in Traumatic States?

Reeds, P. J., Fjeld, C. R., & Jahoor, F. (1994) · The Journal of Nutrition · doi:10.1093/jn/124.6.906 · Cited by 335

The role of C-reactive protein as a prognostic indicator in advanced cancer

Mahmoud, F. A., & Rivera, N. I. (2002) · Current Oncology Reports · doi:10.1007/s11912-002-0023-1 · Cited by 325

Dystrophin glycoprotein complex dysfunction: A regulatory link between muscular dystrophy and cancer cachexia

Acharyya, S., Butchbach, M. E. R., Sahenk, Z., Wang, H., Saji, M., Carathers, M., Ringel, M. D., Skipworth, R. J. E., Fearon, K. C. H., Hollingsworth, M. A., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.004 · Cited by 314

Increased plasma ghrelin level in lung cancer cachexia.

Shimizu, Y., Nagaya, N., Isobe, T., Imazu, M., Okumura, H., Hosoda, H., Kojima, M., Kangawa, K., & Kohno, N. (2003) · PubMed · Cited by 284

Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study.

Ovesen, L., Allingstrup, L., Hannibal, J., Mortensen, E. L., & Hansen, O. P. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.10.2043 · Cited by 271

Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients.

Hirai, K., Hussey, H., Barber, M. D., Price, S. A., & Tisdale, M. J. (1998) · PubMed · Cited by 244

Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies

Laviano, A., Meguid, M. M., & Rossi-Fanelli, F. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01247-6 · Cited by 241

Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and function: A randomized prospective study

Lundholm, K., Daneryd, P., Bosaeus, I., Körner, U., & Lindholm, E. (2004) · Cancer · doi:10.1002/cncr.20160 · Cited by 235

Megestrol acetate for treatment of anorexia-cachexia syndrome

Berenstein, G., & Ortiz, Z. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004310.pub2 · Cited by 206

Pathophysiology of cancer cachexia: Much more than host–tumour interaction?

Skipworth, R. J. E., Stewart, G. D., Dejong, C. H. C., Preston, T., & Fearon, K. C. H. (2007) · Clinical Nutrition · doi:10.1016/j.clnu.2007.03.011 · Cited by 197

Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in vivo. Evidence for distinct mechanisms in regulation of net amino acid deposition.

Tessari, P., Inchiostro, S., Biolo, G., Trevisan, R., Fantin, G., Marescotti, M. C., Iori, E., Tiengo, A., & Crepaldi, G. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112919 · Cited by 193

Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients

Wolf, I., Sadetzki, S., Kanety, H., Kundel, Y., Pariente, C., Epstein, N., Oberman, B., Catane, R., Kaufman, B., & Shimon, I. (2006) · Cancer · doi:10.1002/cncr.21690 · Cited by 184

Prednisolone as an appetite stimulant in patients with cancer.

Willox, J. C., Corr, J., Shaw, J., Richardson, M., Calman, K. C., & Drennan, M. (1984) · BMJ · doi:10.1136/bmj.288.6410.27 · Cited by 180

Cancer-Associated Cachexia and Underlying Biological Mechanisms

Baracos, V. E. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111151 · Cited by 177

A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss

McMillan, D. C., Wigmore, S. J., Wigmore, K. C. H., O’Gorman, P., Wright, C. E., & McArdle, C. S. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690077 · Cited by 174

Cancer cachexia: Metabolic alterations and clinical manifestations

Tisdale, M. J. (1997) · Nutrition · doi:10.1016/s0899-9007(96)00313-9 · Cited by 170

Elevation of cytokine levels in cachectic patients with prostate carcinoma

Pfitzenmaier, J., Vessella, R., Higano, C. S., Noteboom, J. L., Wallace, D., & Corey, E. (2003) · Cancer · doi:10.1002/cncr.11178 · Cited by 167

Cytokines in the pathogenesis of cancer cachexia

Argilés, J. M., Busquets, S., & López-Soriano, F. J. (2003) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000078983.18774.cc · Cited by 165

Nutritional support in multimodal therapy for cancer cachexia

Bosaeus, I. G. (2008) · Supportive Care in Cancer · doi:10.1007/s00520-007-0388-7 · Cited by 153

Short‐term bed rest impairs amino acid‐induced protein anabolism in humans

Biolo, G., Ciocchi, B., Lebenstedt, M., Barazzoni, R., Zanetti, M., Platen, P., Heer, M. A., & Guarnieri, G. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.066365 · Cited by 149

Daily energy expenditure and basal metabolic rates of patients with spinal cord injury.

MOLLINGER, L. A., Spurr, G. B., Ghatit, A. Z. E., Barboriak, J. J., Rooney, C. B., Davidoff, D., & Bongard, R. D. (1985) · PubMed · Cited by 147

Angiotensin II directly induces muscle protein catabolism through the ubiquitin–proteasome proteolytic pathway and may play a role in cancer cachexia

Sanders, P. M., Russell, S. T., & Tisdale, M. J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602725 · Cited by 147

Insulin Treatment in Cancer Cachexia: Effects on Survival, Metabolism, and Physical Functioning

Lundholm, K., Körner, U., Gunnebo, L., Sixt-Ammilon, P., Fouladiun, M., Daneryd, P., & Bosaeus, I. G. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2720 · Cited by 145

Weight Gain Prior to Diagnosis and Survival from Breast Cancer

Cleveland, R. J., Eng, S. M., Abrahamson, P. E., Britton, J. A., Teitelbaum, S. L., Neugut, A. I., & Gammon, M. D. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0889 · Cited by 142

Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight loss

Khal, J., Hine, A. V., Fearon, K. C. H., Dejong, C. H. C., & Tisdale, M. J. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.017 · Cited by 141

Fibrinogen Synthesis Is Elevated in Fasting Cancer Patients with an Acute Phase Response

Preston, T., Slater, C., McMillan, D. C., Falconer, J. S., Shenkin, A., & Fearon, K. C. H. (1998) · Journal of Nutrition · doi:10.1093/jn/128.8.1355 · Cited by 124

A polymorphism of the interleukin-1 β gene influences survival in pancreatic cancer

Barber, M. D., Powell, J. J., Lynch, S. F., Fearon, K. C. H., & Ross, J. A. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1479 · Cited by 117

Elevated tumour interleukin-1β is associated with systemic inflammation: a marker of reduced survival in gastro-oesophageal cancer

Deans, D. A. C., Wigmore, S. J., Gilmour, H. M., Paterson‐Brown, S., Ross, J. A., & Fearon, K. C. H. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603446 · Cited by 110

Ubiquitin-proteasome-dependent proteolysis in skeletal muscle.

Attaix, D., Aurousseau, E., Combaret, L., Kee, A., Larbaud, D., Rallière, C., Souweine, B., Taillandier, D., & Tilignac, T. (1998) · Reproduction Nutrition Development · doi:10.1051/rnd:19980202 · Cited by 109

Metabolic consequences of physical inactivity

Biolo, G., Ciocchi, B., Stulle, M., Piccoli, A., Lorenzon, S., Mas, V. D., Barazzoni, R., Zanetti, M., & Guarnieri, G. (2005) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2004.09.009 · Cited by 109

IL-6-Like Cytokines and Cancer Cachexia: Consequences of Chronic Inflammation

Barton, B. E. (2001) · Immunologic Research · doi:10.1385/ir:23:1:41 · Cited by 104

Daily Physical-Rest Activities in Relation to Nutritional State, Metabolism, and Quality of Life in Cancer Patients with Progressive Cachexia

Fouladiun, M., Körner, U., Gunnebo, L., Sixt-Ammilon, P., Bosaeus, I. G., & Lundholm, K. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1147 · Cited by 104

Systemic inflammation correlates with increased expression of skeletal muscle ubiquitin but not uncoupling proteins in cancer cachexia

Dejong, C. H. C., Busquets, S., Moses, A. G. W., Schrauwen, P., Ross, J. A., Argilés, J. M. A., & Fearon, K. C. H. (2005) · Oncology Reports · doi:10.3892/or.14.1.257 · Cited by 90

Hypogonadism in male patients with metastatic cancer prior to chemotherapy.

Chlebowski, R. T., & Heber, D. (1982) · PubMed · Cited by 90

Objective Physical Activity and Self-Reported Quality of Life in Patients Receiving Palliative Chemotherapy

Dahele, M. R., Skipworth, R. J. E., Wall, L. R., Voss, A., Preston, T., & Fearon, K. C. H. (2007) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.09.024 · Cited by 88

Association of IL-1beta gene polymorphism with cachexia from locally advanced gastric cancer

Zhang, D., Zheng, H., Zhou, Y., Tang, X., Baojun, Y., & Li, J. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-45 · Cited by 81

Cachexia and Wasting: A Modern Approach

Mantovani, G., Yeh, S., Schuster, M. W., Scevola, D., Morley, J. E., Inui, A., Fanelli, F. R., & Anker, S. D. (2006) · Springer eBooks · doi:10.1007/978-88-470-0552-5 · Cited by 74

Latency, Duration and Dose Response Relationships of Amino Acid Effects on Human Muscle Protein Synthesis

Rennie, M. J., Bohé, J., & Wolfe, R. R. (2002) · The Journal of Nutrition · doi:10.1093/jn/131.10.3225s · Cited by 74

Cancer Anorexia-Cachexia Syndrome

McClement, S. (2005) · Journal of Wound Ostomy and Continence Nursing · doi:10.1097/00152192-200507000-00012 · Cited by 67

Host Cytokine Genotype is Related to Adverse Prognosis and Systemic Inflammation in Gastro-Oesophageal Cancer

Deans, C., Rose-Zerilli, M. J. J., Wigmore, S. J., Ross, J. A., Howell, M. W., Jackson, A. A., Grimble, R. F., & Fearon, K. C. H. (2006) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9122-9 · Cited by 63

Liver export protein synthetic rates are increased by oral meal feeding in weight-losing cancer patients

Barber, M. D., Fearon, K. C. H., McMillan, D. C., Slater, C., Ross, J. A., & Preston, T. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.3.e707 · Cited by 51

Research methodology: cancer cachexia syndrome

Dahele, M. R., & Fearon, K. (2004) · Palliative Medicine · doi:10.1191/0269216304pm906ra · Cited by 49

Insulin action on glucose and branched-chain amino acid metabolism in cancer cachexia: differential effects of insulin.

Pisters, P. W. T., Cersósimo, E., Rogatko, A., et al. (1992) · PubMed · Cited by 43

Tumor host relations

Schaur, R. J., Fellier, H., Gleispach, H., Fink, E., & Kronberger, L. (1979) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00964584 · Cited by 41

Is bortezomib, a proteasome inhibitor, effective in treating cancer-associated weight loss? Preliminary results from the North Central Cancer Treatment Group

Jatoi, A., Alberts, S. R., Foster, N. R., Morton, R. F., Burch, P. A., Block, M., Nguyen, P. L., & Kugler, J. W. (2005) · Supportive Care in Cancer · doi:10.1007/s00520-005-0787-6 · Cited by 33

The molecular mechanisms of skeletal muscle wasting: Implications for therapy

Skipworth, R. J. E., Stewart, G. D., Ross, J. A., Guttridge, D. C., & Fearon, K. C. H. (2006) · The Surgeon · doi:10.1016/s1479-666x(06)80004-1 · Cited by 25

Targets in clinical oncology: the metabolic environment of the patient

Argilés, J. M. A. (2007) · Frontiers in bioscience · doi:10.2741/2293 · Cited by 22

Cachexia and Wasting: A Modern Approach

Fabbro, E. D. (2007) · JAMA · doi:10.1001/jama.297.5.536 · Cited by 19

A Critical Assessment of the Outcome Measures and Goals of Intervention in Cancer Cachexia

Fearon, K. C. H., & Skipwoth, R. J. E. (2007) · Springer eBooks · doi:10.1007/978-88-470-0552-5_59 · Cited by 2

Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region

Lipton (1995) · Pure Amsterdam UMC · doi:10.1002/1097-0142(19950415)75:8 · Cited by 1

ESPEN guidelines on nutrition in cancer patients

Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Fearon, K., Hütterer, E., Isenring, E., Kaasa, S., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.07.015 · Cited by 3,114

Cancer-associated cachexia

Baracos, V. E., Martin, L., Korc, M., Guttridge, D. C., & Fearon, K. C. H. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.105 · Cited by 1,738

Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways

Fearon, K. C. H., Glass, D. J., & Guttridge, D. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.011 · Cited by 1,205

Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival

Zhou, X., Wang, J. L., Lu, J., Song, Y., Kwak, K. S., Jiao, Q., Rosenfeld, R., Chen, Q., Boone, T., Simonet, W. S., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.011 · Cited by 940

Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines☆

Arends, J., Strasser, F., Gonella, S., Solheim, T. S., Madeddu, C., Ravasco, P., Buonaccorso, L., de van der Schueren, M. A. E., Baldwin, C., Chasen, M., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100092 · Cited by 586